Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
life sciences
national blog main
san diego blog main
san diego top stories
achaogen
adams street partners
antibiotics
beta lactamase inhibitor
bill & melinda gates foundation
biomedical advanced research and development authority (barda)
biotech ipos
boston
boston blog main
boston top stories
ceo
co-founder
deals
disease
drug resistance
drugs
dyne therapeutics
gates foundation
hatteras venture partners
health
healthcare
hiv
investing
lawyer
lyzz capital
macrolide pharmaceuticals
massachusetts institute of technology
medication
melinta therapeutics
meropenem
metacrine
michael dudley
myotonic dystrophy type 1
What
company
3
×
drug
3
×
therapeutics
3
×
developing
medicines
million
raised
acting
aiming
bacteria
biopharma
brings
business
change
consumption
continue
creating
delayed
delivery
disease
disorders
dyne
dyne’s
exited
fighting
genetic
infections
infectious
ipo
kind
launches
little
long
lyndra
mecha
medicine
melinta
muscle
muscular
new
Language
unset
Current search:
drug
×
therapeutics
×
company
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@techcrunch.com
5 years ago
Aiming to change the way people take medicine, Lyndra Therapeutics raises $55 million
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
